Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million
MWN-AI** Summary
Cosmos Health Inc., a diversified global healthcare group based in Chicago, has announced a significant expansion of its digital asset portfolio through the acquisition of an additional $200,000 in Ethereum (ETH). This investment brings Cosmos Health's total ETH holdings to $2 million, executed under its $300 million digital assets facility. CEO Greg Siokas highlighted this milestone as a pivotal step in the company’s strategy to diversify and strengthen its asset base via targeted digital investments.
Established in 2009, Cosmos Health has positioned itself as a vertically integrated healthcare leader with a wide range of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life® and Mediterranation®. The company operates manufacturing facilities in compliance with European Good Manufacturing Practices (GMP) and is licensed by the European Medicines Agency (EMA) to produce a variety of healthcare products. With subsidiaries across Greece and the UK, Cosmos Health distributes pharmaceuticals and engages in R&D partnerships aimed at tackling significant health issues such as obesity and diabetes.
In addition to its pharmaceutical endeavors, Cosmos Health has ventured into the telehealth sector with the acquisition of ZipDoctor, Inc., enhancing its service offerings. The company is actively expanding its reach in Europe, Asia, and North America, supported by strategic partnerships and a robust distribution network.
Despite the optimistic outlook, investors are reminded to consider the inherent risks associated with forward-looking statements, including potential market fluctuations and operational challenges related to the ongoing geopolitical climate. As Cosmos Health continues to implement its digital asset strategy, stakeholders are encouraged to remain vigilant about the global factors that could impact its business trajectory.
MWN-AI** Analysis
Cosmos Health Inc. (NASDAQ: COSM) continues to strengthen its position within the digital asset landscape through strategic investments in Ethereum, recently committing an additional $200,000, raising its total investment to $2 million. This move falls under its broader $300 million digital assets facility, aiming to diversify and enhance its asset base.
This strategic allocation towards Ethereum is noteworthy, especially given the cryptocurrency's fluctuating volatility and market sentiment. For investors, this presents both opportunity and risk. Cosmos Health's consistent commitment to digital assets signals confidence in the long-term viability of cryptocurrencies, primarily Ethereum, as a valuable component of their investment strategy. Given Ethereum's historical performance and the robust ecosystem surrounding it—especially with the ongoing development of decentralized applications and smart contracts—the position may yield significant returns in future bull markets.
Moreover, Cosmos Health's broader business diversification, which includes pharmaceuticals, nutraceuticals, and telehealth services, reduces the risk typically associated with tech-heavy investments. The company's global expansion strategy in Europe, Asia, and North America strengthens its operational resilience, potentially bolstering its market share amidst fluctuating crypto values.
Investors should also consider potential market risks outlined in Cosmos Health’s recent filings, specifically regarding the unpredictability of digital asset markets, which could impact the company’s ability to meet its aspirations. While Cosmos pursues innovative healthcare solutions and integrates cutting-edge developments, the effect of external pressures, such as geopolitical tensions and economic shifts, could temper growth expectations.
In conclusion, while Cosmos Health's incremental investment in Ethereum enhances its digital portfolio, investors should weigh these opportunities against the inherent risks of volatility in both cryptocurrency and broader markets. A balanced approach, monitoring both performance and external conditions, is advisable for stakeholders considering engagement with Cosmos Health's diversified offerings.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
CHICAGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has acquired an additional $200,000 worth of Ethereum (ETH), bringing the Company’s total investment in ETH to $2 million.
This purchase was executed under Cosmos Health’s previously announced $300 million digital assets facility, which underpins the Company’s strategy to broaden and strengthen its portfolio through targeted digital asset investments.
Greg Siokas, CEO of Cosmos Health, stated: “Reaching the $2 million milestone in our Ethereum investment marks another important step in our digital asset expansion strategy. We remain steadfast in our commitment to leveraging our $300 million financing facility to further diversify and enhance our long-term asset base.”
About Cosmos Health Inc.
Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com , www.skypremiumlife.com , www.cana.gr , www.zipdoctor.co , www.cloudscreen.gr , as well as LinkedIn and X .
Forward-Looking Statements
With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” “plans,” and similar expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could,” generally identify forward-looking statements, although not all forward-looking statements contain these words. These statements involve risks and uncertainties that may individually or materially affect the matters discussed herein for a variety of reasons outside the Company’s control, including, but not limited to: the Company’s ability to raise sufficient financing to implement its business plan; the effectiveness of its digital asset strategies, including accumulation and yield-generating activities; the impact of the war in Ukraine on the Company’s business, operations, and the economy in general; and the Company’s ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those anticipated. Readers are encouraged to review the risk factors set forth in the Company’s filings with the SEC, which are available at the SEC’s website ( www.sec.gov ). The Company disclaims any obligation to update or revise forward-looking statements, whether as a result of new information, future events, or otherwise
Investor Relations Contact:
BDG Communications
cosm@bdgcommunications.com
Disclaimer
This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a COSM financial position. COSM financial position and all other information regarding the featured Company should be verified directly with COSM. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in COSM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of COSM shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Compensation: Market Wire News and its affiliates has received six thousand dollars for Market Wire News advertising services from Relqo Media LLC for Brand Awareness Distribution, Corporate Communications, News, Press Release Enhancement and Social Media Solutions starting 2026-05-31 and ending 2026-06-05 provided by Market Wire News. To date, we have received a total of six thousand dollars. Please read our full disclaimer for compensation and more detailed information.
FAQ**
How does Cosmos Health Inc. plan to utilize its $300 million digital assets facility to further diversify its investment strategy beyond the current purchase of Ethereum, as highlighted in the recent announcement about Cosmos Holdings Inc. COSM?
What specific metrics or milestones will Cosmos Health Inc. use to evaluate the success of its digital asset investments, particularly the $2 million allocation to Ethereum, as part of its overall strategy at Cosmos Holdings Inc. COSM?
In light of recent market volatility for cryptocurrencies, how does Cosmos Health Inc. intend to mitigate risks associated with its digital assets investments while adhering to its growth strategy as evidenced by Cosmos Holdings Inc. COSM's actions?
How will the integration of telehealth services through ZipDoctor, Inc. complement Cosmos Health Inc.’s digital asset strategy and overall healthcare offerings in the context of upcoming initiatives associated with Cosmos Holdings Inc. COSM?
**MWN-AI FAQ is based on asking OpenAI questions about Cosmos Health Inc. (NASDAQ: COSM).
NASDAQ: COSM
COSM Trading
-3.36% G/L:
$0.2505 Last:
367,675 Volume:
$0.264 Open:



